Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and safety of 0.01% atropine eye drops with different dosing frequencies for myopia control in school-age children
ChiCTR2200055532Phase 4Recruiting
- Sponsor
- Tianjin Medical University Eye Hospital
- Start
- Jan 2022
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of atropine in myopia (2 arms), sponsored by Tianjin Medical University Eye Hospital. Primary endpoints: axial length, refractive error and 1 more. Started Jan 2022; status: recruiting.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on ChiCTR2200055532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055532.